Literature DB >> 2123042

[Influence of health education on compliance with antituberculous chemoprophylaxis in children: a community trial].

J Alcaide Megías, M N Altet Gómez, J Canela Soler, L Serra Majen, P Garrido Morales, E Navas Alcalá, M R Suñé Puigbó, L Salleras Sanmartí.   

Abstract

Antituberculous chemoprophylaxis with isoniazide during a period of one year is very useful although it is not readily accepted. A community trial is designed in order to test if three health education interventions increase patients compliance with such treatment in case of tuberculin positive children who are not ill. The two interventions performed by nurses, one by phone, and the second one by a home visit, resulted in statistically significant difference when compared to the control group. This did not occur, however, with the intervention performed by the doctor in his office. A cost-effectiveness study demonstrates that the most efficient intervention has been the phone call.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123042

Source DB:  PubMed          Journal:  Rev Clin Esp        ISSN: 0014-2565            Impact factor:   1.556


  4 in total

Review 1.  [Treatment compliance: what do we know about Spain?].

Authors:  A Rigueira García
Journal:  Aten Primaria       Date:  2001-05-15       Impact factor: 1.137

Review 2.  Patient education and counselling for promoting adherence to treatment for tuberculosis.

Authors:  James Machoki M'imunya; Tamara Kredo; Jimmy Volmink
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 3.  Telephone follow-up, initiated by a hospital-based health professional, for postdischarge problems in patients discharged from hospital to home.

Authors:  P Mistiaen; E Poot
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

Review 4.  Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment.

Authors:  Qin Liu; Katharine Abba; Marissa M Alejandria; David Sinclair; Vincent M Balanag; Mary Ann D Lansang
Journal:  Cochrane Database Syst Rev       Date:  2014-11-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.